In the latest market close, Applied Materials (AMAT) reached $178.80, with a -0.86% movement compared to the previous day. The stock fell short of the S&P 500, which registered a loss of 0.76% for the ...
Applied Materials (AMAT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
High-quality company Applied Materials is set for growth in the semiconductor market, but current valuation limits short-term ...
Applied Materials Inc (AMAT) stock saw a decline, ending the day at $186.75 which represents a decrease of $-3.95 or -2.07% from the prior close of $190.7. The stock opened at $190.89 and touched a ...
We recently compiled a list of the 10 Best Semiconductor Stocks to Buy for the AI Boom. In this article, we are going to take ...
Applied Materials Inc (AMAT) stock saw a decline, ending the day at $172.85 which represents a decrease of $-1.72 or -0.99% from the prior close of $174.57. The stock opened at $173.75 and touched a ...
Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three ...
In this article, we are going to take a look at where Applied Materials, Inc. (NASDAQ:AMAT) stands against other undervalued semiconductor stocks to buy according to analysts. Global market ...
KeyBanc analyst Steve Barger upgraded Applied Materials (AMAT – Research Report) to a Buy yesterday and set a price target of $225.00. The ...
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Applied Mat's whale activity within a strike price range from $175.0 to $230.0 in the ...
A Thai senator sparked controversy after calling for the death penalty for drug offenders and the broadcasting of their executions.
Below is Validea's guru fundamental report for APPLIED MATERIALS INC (AMAT). Of the 22 guru strategies we follow, AMAT rates highest using our Patient Investor model based on the published ...